Notably, systemic inflammation, estimated either from elevated circulating interleukin-6 (IL-6) or C-reactive protein (CRP) levels, has been reported as an important clinical factor associated with increased mortality risk, and whereas this is well documented and quantified for CRP in the general population, this is less clear for IL-6 in the dialysis CKD population. This evidence concerns the gene CRP and chronic kidney disease.